Protagonist Therapeutics, Inc. (PTGX)

91.14 +2.58 (+2.91%) USD  |  NASDAQ  |  Dec 10, 14:10
More

Protagonist Therapeutics Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade